1.Clinical effects of ganciclovir combined with gangliosides and gamma globulin in treating children with viral encephalitis
Songyi GAO ; Qinghua DANG ; Xiaoqian GAO ; Yan SUN ; Wenjing ZHAO
Drug Evaluation Research 2017;40(3):373-376
Objective To compare the clinical effect and safety evaluation of three different dose regimens for treating children with viral encephalitis.Methods Totally 126 cases treated in Xi'an Central Hospital from January 2010 to December 2015 were randomly divided into observation group 1 (ganciclovir combined with gangliosides,42 cases),observation group 2 (ganciclovir combined with gamma globulin,43 cases),and control group (39 cases).The clinical effect and levels of NSE,inflammatory cytokine were compared in the three groups.Results The total effective rate in observation group 1 was 95.24% and that of observation group 2 was 93.02%,which were significantly higher than that of control group (79.48%).The disappearance time of headache,fever,convulsions,clouding of consciousness,meningeal irritation sign,cerebrospinal fluid abnormalities,and length of stay in observation groups (both 1 and 2)were significantly shorter than those in control group (P < 0.05);After therapy,the levels of NSE in three groups were obviously decreased compared with those before therapy (P < 0.05),and those in observation group were significantly lower than the control group (P < 0.05);the levels of inflammatory cytokine in all three groups were obviously decreased compared with those before therapy (P < 0.05),and that of observation group 1 had no statistical difference with the normal group,whereas that in control group was significantly higher than the normal group (P < 0.05).Conclusion Ganciclovir combined with gangliosides as well as ganciclovir combined with gamma globulin were both effective methods in treating children with viral encephalitis and could decrease levels of inflammatory cytokine.Ganciclovir combined with gangliosides could effectively repair nerve damage,which deserves clinical expansion.
2.Comparison of the Clinical Effect and Safety of Three Dosage Regimens in the Treatment of Children with Severe Pneumonia
Wenjing ZHAO ; Ting AI ; Qinghua DANG ; Yan SUN ; Xiaoqian GAO ; Songyi GAO
Progress in Modern Biomedicine 2017;17(26):5141-5144
Objective:To compare the clinical effect and safety of three different regimens treating children with severe pneumonia.Methods:120 cases treated in our hospital from January,2012 to January,2016 were randomly divided into the observation group 1 (dopamine combined with dobutamine,42 cases),observation group 2 (dopamine combined with phentolamine,40 cases),control group (38 cases).The clinical effect and levels of inflammatory cytokine were compared between the three groups.Results:The total effective rate in the observation group 1 was 90.48% and that of observation group 2 was 87.5%,which were significantly higher than that of the control group (63.16%).The disappearance time of pulmonary rales,cough,dyspnea,pyretolysis and length of stay in the observation group (both 1,2) were significantly shorter than those of the control group (p <0.05).After therapy,the level of serum IL-6,IL-8,CRP and TNF-α in all the three groups were obviously decreased compared with those of before therapy (p<0.05),and those of the observation group were significantly lower than the control group (p < 0.05).Conclusion:Dopamine combined with dobutamine as well as dopamine combined with phentolamine were both effective methods in treating children with severe pneumonia,which were significantly better than conventional therapy.